These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 30912281)

  • 21. Prevalence and Factors Associated with Potential Drug-Drug Interactions in Older Community-Dwelling Adults: A Prospective Cohort Study.
    Hughes JE; Russo V; Walsh C; Menditto E; Bennett K; Cahir C
    Drugs Aging; 2021 Nov; 38(11):1025-1037. PubMed ID: 34632551
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potential drug-drug interactions with abiraterone in metastatic castration-resistant prostate cancer patients: a prevalence study in France.
    Bonnet C; Boudou-Rouquette P; Azoulay-Rutman E; Huillard O; Golmard JL; Carton E; Noé G; Vidal M; Orvoen G; Chah Wakilian A; Villeminey C; Blanchet B; Alexandre J; Goldwasser F; Thomas-Schoemann A
    Cancer Chemother Pharmacol; 2017 May; 79(5):1051-1055. PubMed ID: 28361167
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug interactions detected by a computer-assisted prescription system in primary care patients in Spain: MULTIPAP study.
    Rogero-Blanco E; Del-Cura-González I; Aza-Pascual-Salcedo M; García de Blas González F; Terrón-Rodas C; Chimeno-Sánchez S; García-Domingo E; López-Rodríguez JA;
    Eur J Gen Pract; 2021 Dec; 27(1):90-96. PubMed ID: 33982632
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factors Affecting Discharge to Home of Geriatric Intermediate Care Facility Residents in Japan.
    Morita K; Ono S; Ishimaru M; Matsui H; Naruse T; Yasunaga H
    J Am Geriatr Soc; 2018 Apr; 66(4):728-734. PubMed ID: 29461630
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potential drug interactions with antibacterials in long-term care facilities analyzed by two interaction checkers.
    Štuhec M; Potočin I; Stepan D; Ušaj L; Petek Šter M; Beović B
    Int J Clin Pharm; 2019 Aug; 41(4):932-938. PubMed ID: 31172409
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 2020 FDA Drug-drug Interaction Guidance: A Comparison Analysis and Action Plan by Pharmaceutical Industrial Scientists.
    Sudsakorn S; Bahadduri P; Fretland J; Lu C
    Curr Drug Metab; 2020; 21(6):403-426. PubMed ID: 32562522
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of drug-drug interactions for oncology therapies: in vitro-in vivo extrapolation model-based risk assessment.
    Waters NJ
    Br J Clin Pharmacol; 2015 Jun; 79(6):946-58. PubMed ID: 25443889
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polypharmacy is associated with frailty in Japanese community-dwelling older adults.
    Yuki A; Otsuka R; Tange C; Nishita Y; Tomida M; Ando F; Shimokata H
    Geriatr Gerontol Int; 2018 Oct; 18(10):1497-1500. PubMed ID: 30168240
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exposure to potential CYP450 pharmacokinetic drug-drug interactions among osteoarthritis patients: incremental risk of multiple prescriptions.
    Pergolizzi JV; Labhsetwar SA; Puenpatom RA; Joo S; Ben-Joseph R; Summers KH
    Pain Pract; 2011; 11(4):325-36. PubMed ID: 21199317
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The influence of educational level on polypharmacy and inappropriate drug use: a register-based study of more than 600,000 older people.
    Haider SI; Johnell K; Weitoft GR; Thorslund M; Fastbom J
    J Am Geriatr Soc; 2009 Jan; 57(1):62-9. PubMed ID: 19054196
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetic drug interactions between clobazam and drugs metabolized by cytochrome P450 isoenzymes.
    Walzer M; Bekersky I; Blum RA; Tolbert D
    Pharmacotherapy; 2012 Apr; 32(4):340-53. PubMed ID: 22422635
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence and differences in the co-administration of drugs known to interact: an analysis of three distinct and large populations.
    Sánchez-Valle J; Correia RB; Camacho-Artacho M; Lepore R; Mattos MM; Rocha LM; Valencia A
    BMC Med; 2024 Apr; 22(1):166. PubMed ID: 38637816
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polypharmacy in patients with advanced cancer and pain: a European cross-sectional study of 2282 patients.
    Kotlinska-Lemieszek A; Paulsen O; Kaasa S; Klepstad P
    J Pain Symptom Manage; 2014 Dec; 48(6):1145-59. PubMed ID: 24780183
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potential drug-drug interactions in older adults: A population-based study.
    Santos TRA; Silveira EA; Pereira LV; Provin MP; Lima DM; Amaral RG
    Geriatr Gerontol Int; 2017 Dec; 17(12):2336-2346. PubMed ID: 28635169
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of Cardiovascular Diseases Among Elderly Residents of Long-term Care Facilities.
    Kańtoch A; Gryglewska B; Wójkowska-Mach J; Heczko P; Grodzicki T
    J Am Med Dir Assoc; 2018 May; 19(5):428-432. PubMed ID: 29402648
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence and predictors of potential drug-drug interactions in Regione Emilia-Romagna, Italy.
    Gagne JJ; Maio V; Rabinowitz C
    J Clin Pharm Ther; 2008 Apr; 33(2):141-51. PubMed ID: 18315779
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polypharmacy and mortality among nursing home residents with advanced cognitive impairment: results from the SHELTER study.
    Onder G; Liperoti R; Foebel A; Fialova D; Topinkova E; van der Roest HG; Gindin J; Cruz-Jentoft AJ; Fini M; Gambassi G; Bernabei R;
    J Am Med Dir Assoc; 2013 Jun; 14(6):450.e7-12. PubMed ID: 23647778
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of adherence to renal dosing guidelines in long-term care facilities.
    Papaioannou A; Clarke JA; Campbell G; Bédard M
    J Am Geriatr Soc; 2000 Nov; 48(11):1470-3. PubMed ID: 11083325
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparing the Prevalence of Polypharmacy and Potential Drug-Drug Interactions in Nursing Homes and in the Community Dwelling Elderly of Emilia Romagna Region.
    Burato S; Leonardi L; Antonazzo IC; Raschi E; Ajolfi C; Baraghini M; Chiarello A; Delmonte V; Di Castri L; Donati M; Fadda A; Fedele D; Ferretti A; Gabrielli L; Gobbi S; Lughi S; Mazzari M; Pieraccini F; Renzetti A; Russi E; Scanelli C; Zanetti B; Poluzzi E
    Front Pharmacol; 2020; 11():624888. PubMed ID: 33628186
    [No Abstract]   [Full Text] [Related]  

  • 40. Trends and Determinants of Polypharmacy and Potential Drug-Drug Interactions at Discharge From Hospital Between 2009-2015.
    Abolhassani N; Castioni J; Santschi V; Waeber G; Marques-Vidal P
    J Patient Saf; 2021 Dec; 17(8):e1171-e1178. PubMed ID: 29557932
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.